Intrinsic Value of S&P & Nasdaq Contact Us

American Healthcare REIT, Inc. AHR NYSE

NYSE • Real Estate • REIT - Healthcare Facilities • US • USD

SharesGrow Score
50/100
2/7 Pass
SharesGrow Intrinsic Value
$18.29
-62.5%
Analyst Price Target
$53.33
+9.2%

American Healthcare REIT, Inc. (AHR) is a REIT - Healthcare Facilities company in the Real Estate sector, currently trading at $48.82. It has a SharesGrow Score of 50/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of AHR = $18.29 (-62.5% from the current price, the stock appears overvalued). Analyst consensus target is AHR = $53 (+9.2% upside).

Valuation: AHR trades at a trailing Price-to-Earnings (P/E) of 115.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.72.

Financials: revenue is $2.3B, +11.8%/yr average growth. Net income is $70M, growing at +114.6%/yr. Net profit margin is 3.1% (thin). Gross margin is 1.8% (-19 pp trend).

Balance sheet: total debt is $1.6B against $3.3B equity (Debt-to-Equity (D/E) ratio 0.48, conservative). Debt-to-assets is 29.3%. Total assets: $5.4B.

Analyst outlook: 10 / 11 analysts rate AHR as buy (91%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 42/100 (Partial), Growth 90/100 (Pass), Past 25/100 (Fail), Health 50/100 (Partial), Moat 24/100 (Fail), Future 88/100 (Pass), Income 30/100 (Fail).

$53.33
▲ 9.24% Upside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for American Healthcare REIT, Inc., the average price target is $53.33, with a high forecast of $60.00, and a low forecast of $43.00.
Highest Price Target
$60.00
Average Price Target
$53.33
Lowest Price Target
$43.00

AHR SharesGrow Score Overview

50/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 42/100
Valuation — P/E, PEG, Forward PEG
GROWTH 90/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 24/100
Gross margin is + market cap
FUTURE 88/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — AHR

~
VALUE Partial
42/100
AHR trades at a trailing Price-to-Earnings (P/E) of 115.8 (S&P 500 average ~25). Forward PEG 3.72 — overvalued. Trailing PEG 0.6. Analyst consensus target is $53, implying +8.6% from the current price $49. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
90/100
AHR: +11.8%/yr revenue is, +114.6%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Fail
25/100
AHR: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet AHR: Debt-to-Equity (D/E) ratio 0.48 (conservative), Current ratio is N/A. Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Fail
24/100
AHR: Gross margin is 1.8% (-19 pp trend), $9B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 24/100. ≥ 70 = Pass.
View details →
FUTURE Pass
88/100
Analyst outlook: 10 / 11 analysts rate AHR as buy (91%). Analyst consensus target is $53 (+8.6% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
30/100
AHR: Net profit margin is 3.1%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range26.48-54.67
Volume1.76M
Avg Volume (30D)3.02M
Market Cap$9.18B
Beta (1Y)1.18
Dividend Yield$1.0000
Share Statistics
EPS (TTM)0.42
Shares Outstanding$166.06M
IPO Date2024-02-07
Employees114
CEOJeff Hanson
Financial Highlights & Ratios
Revenue (TTM)$2.26B
Gross Profit$39.69M
EBITDA$321.98M
Net Income$69.81M
Operating Income$167.83M
Total Cash$114.84M
Total Debt$1.59B
Net Debt$1.47B
Total Assets$5.43B
Price / Earnings (P/E)116.2
Price / Sales (P/S)4.06
Analyst Forecast
1Y Price Target$55.00
Target High$60.00
Target Low$43.00
Upside+12.7%
Rating ConsensusBuy
Analysts Covering11
Buy 91% Hold 9% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS3981823038

Price Chart

AHR
American Healthcare REIT, Inc.  ·  NYSE
Real Estate • REIT - Healthcare Facilities
26.48 52WK RANGE 54.67
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message